Single Cell Kickoff

Single Cell Focus Area Kick-Off Symposium

Single-cell technologies are revolutionizing biomedical research by allowing the investigation of individual cells and the molecular changes that lead to disease with unprecedented detail both in time and space. However, the translation of basic findings into the clinical routine for early diagnosis and personalized therapies poses many challenges. The BIH, Charité and MDC joined forces to establish the new Focus Area “Single Cell Approaches for Personalised Medicine” with the aim of translating single cell discoveries into clinical practice to improve diagnostics, early detection of disease and enable personalised treatments to reach the ultimate goal of increasing patients’ wellbeing.

Long-term corporations between scientists and clinical experts from multiple disciplines are required to successfully integrate single-cell research and medical practice to improve healthcare. Four newly appointed junior groups are now closely collaborating with four leading clinicians to connect basic research with clinical practice. This bridge concept optimally combines the internationally leading position of the BIMSB-MDC in the development of single cell technologies with the clinical-translational potential of BIH/Charité. Moreover, a central bioportal and a clinical single cell sequencing (CSCS) pipeline are being established to streamline the process from sample collection to data analysis, to enable personalized and data driven treatment choices.

We are eager to present the projects and future directions of the Focus Area and the ground breaking potential of this collaborative effort. We kindly invite you to join the Kick-Off Symposium for the BIH, Charité and MDC Focus Area “Single Cell Approaches for Personalized Medicine” held virtually on May 20 2021, from 3pm to 7pm. Breakout rooms will allow participants to meet the speakers and interact.

We are looking forward to excellent talks, inspiring conversations and to welcome you online!

Event kindly supported by Stiftung Charité and Johanna Quandt Foundation

Single Cell: Approaches for Personalized Medicine

Venue

Virtual Meeting via Zoom

Zeit

-


Organisator*innen

Dr. Stefanie Großwendt
Dr. Simon Haas
Dr. Leif Ludwig
Dr. Ashley Sanders


Sponsoren